Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 22, 2009, 10:05AM ET - U.S. Markets close in 5 hours and 55 minutes. Dow  0.37% Nasdaq  0.47%

Theravance Inc. (THRX)

At 9:50AM ET: 13.58   0.09 (0.67%)

MORE ON THRX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Dec 15, 2009 • THERAVANCE INC Files SEC form 8-K, Other Events EDGAR Online (Tue, Dec 15) Fri, Dec 11, 2009 • Gilead Gets the Experts on Its Side at Motley Fool (Fri, Dec 11) Tue, Dec 8, 2009 • Seth Klarman's Biggest Bets at Investopedia (Tue, Dec 8) Wed, Dec 2, 2009 • Theravance to Present at the Deutsche Bank 2009 Biotech Boston Confab Marketwire (Wed, Dec 2) Tue, Dec 1, 2009 • Theravance Announces New Employment Inducement Awards Marketwire (Tue, Dec 1) Mon, Nov 30, 2009 • FDA Denies Approval of Theravance Pneumonia Drug at Fox Business (Mon, Nov 30) • The FDA Moves the Goalposts at Motley Fool (Mon, Nov 30) • BioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance at Seeking Alpha (Mon, Nov 30) • Biotech Stocks: Drug stocks split; Theravance slides on setback at MarketWatch (Mon, Nov 30) • Picks of the Week: Microsoft, H-P, Goldman, TiVo at BusinessWeek (Mon, Nov 30) • Theravance Announces That EMEA Has Completed the Validation Phase for the Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections Marketwire (Mon, Nov 30) Fri, Nov 27, 2009 • UPDATE - FDA denies approval for Theravance's pneumonia drug at Reuters (Fri, Nov 27) • Theravance says FDA delays new Vitabiv decision AP (Fri, Nov 27) • THERAVANCE INC Files SEC form 8-K, Other Events EDGAR Online (Fri, Nov 27) • Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia Marketwire (Fri, Nov 27) Thu, Nov 26, 2009 • Theravance, Inc.: Wait to Buy on Dip at Seeking Alpha (Thu, Nov 26) Fri, Nov 13, 2009 • Unique Strategy Generates Big Returns for Baupost Indie Research (Fri, Nov 13) Tue, Nov 10, 2009 • THERAVANCE INC Financials EDGAR Online Financials (Tue, Nov 10) Thu, Nov 5, 2009 • Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States Marketwire (Thu, Nov 5) Wed, Nov 4, 2009 • THERAVANCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Nov 4) Older Headlines - Download Recent Headlines View headlines from: Wed, Nov 4, 2009Wed, Oct 28, 2009Wed, Oct 21, 2009Wed, Oct 14, 2009Wed, Oct 7, 2009Wed, Sep 30, 2009Wed, Sep 23, 2009Wed, Sep 16, 2009Wed, Sep 9, 2009Wed, Sep 2, 2009 Add THRX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage